Busey Bank
EW icon

Busey Bank’s Edwards Lifesciences EW Stock Holding History

Busey Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$786K Buy
9,103
+8
+0.1% +$711 0.02% 204
2026
Q2 		$823K Sell
9,095
-94
-1% -$7.87K 0.02% 202
2026
Q1 		$736K Sell
9,189
-524
-5% -$43.2K 0.02% 209
2025
Q4 		$828K Sell
9,713
-56
-0.6% -$4.6K 0.02% 197
2025
Q3 		$760K Sell
9,769
-53
-0.5% -$4.14K 0.02% 202
2025
Q2 		$768K Buy
9,822
+2,260
+30% +$169K 0.02% 195
2025
Q1 		$548K Sell
7,562
-323
-4% -$23.1K 0.02% 229
2024
Q4 		$584K Sell
7,885
-788
-9% -$55.2K 0.02% 218
2024
Q3 		$572K Sell
8,673
-165
-2% -$12K 0.02% 228
2024
Q2 		$816K Buy
8,838
+165
+2% +$14.6K 0.03% 186
2024
Q1 		$829K Hold
8,673
– – 0.03% 187
2023
Q4 		$661K Hold
8,673
– – 0.03% 203
2023
Q3 		$601K Sell
8,673
-59
-0.7% -$4.74K 0.03% 205
2023
Q2 		$824K Sell
8,732
-1,541
-15% -$134K 0.03% 191
2023
Q1 		$850K Sell
10,273
-300
-3% -$23.6K 0.04% 190
2022
Q4 		$789K Hold
10,573
– – 0.04% 192
2022
Q3 		$873K Hold
10,573
– – 0.04% 188
2022
Q2 		$1M Sell
10,573
-78
-0.7% -$8.08K 0.05% 183
2022
Q1 		$1.25M Hold
10,651
– – 0.05% 181
2021
Q4 		$1.38M Buy
10,651
+2,994
+39% +$349K 0.05% 172
2021
Q3 		$866K Buy
7,657
+4,833
+171% +$552K 0.03% 201
2021
Q2 		$292K Hold
2,824
– – 0.01% 275
2021
Q1 		$236K Buy
2,824
+61
+2% +$5.16K 0.01% 300
2020
Q4 		$252K Hold
2,763
– – 0.01% 281
2020
Q3 		$221K Buy
+2,763
New +$216K 0.01% 297
2020
Q1 		– Sell
-2,763
Closed -$215K – 361
2019
Q4 		$215K Hold
2,763
– – 0.01% 316
2019
Q3 		$203K Buy
+2,763
New +$194K 0.01% 316
2018
Q4 		– Sell
-4,692
Closed -$272K – 211
2018
Q3 		$272K Buy
+4,692
New +$229K 0.03% 177

Other funds holding EW

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Busey Bank's EW Position: Q3 2026 in Review

Busey Bank increased its Edwards Lifesciences (EW) stake by 0.09% in Q3 2026, buying an estimated $711 and bringing the position to 9,103 shares worth $786K. The position accounts for 0.02% of the portfolio, ranked #204.

Busey Bank first reported a position in EW in Q3 2018 and has held it in 28 quarters since. The position peaked at $1.38M in Q4 2021. 871 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Busey Bank held 9,103 shares of Edwards Lifesciences worth $786K as of Q3 2026.
  • Busey Bank bought 8 Edwards Lifesciences shares in Q3 2026, an estimated $711.
  • Edwards Lifesciences made up 0.02% of Busey Bank's portfolio in Q3 2026, its #204 holding.
  • Busey Bank first reported a position in Edwards Lifesciences in Q3 2018 and has held it in 28 quarters since.
  • Busey Bank's Edwards Lifesciences position peaked at $1.38M in Q4 2021.
  • 871 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Busey Bank's 13F filing for Q3 2026, filed 26 Oct 2026.